Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Publication year range
1.
Med Sante Trop ; 29(4): 399-401, 2019 Nov 01.
Article in English | MEDLINE | ID: mdl-31884994

ABSTRACT

The treatment of cancer, whether a solid tumor or a malignant hemopathy, is accompanied by bouts of infection, the severity and prognosis of which are often correlated to the patient's immune status. In Gabon, where the transmission of Plasmodium falciparum malaria is perennial, the prevalence - around 36% in Libreville - increases in older children and adults. Few authors have described the involvement of this parasite during fever after chemotherapy for hematological malignancies. This work reports three cases of malaria including two severe and one with neutropenia occurring in patients treated for hematological neoplasms.


Subject(s)
Antineoplastic Agents/adverse effects , Lymphoma, Non-Hodgkin/drug therapy , Malaria/chemically induced , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Antineoplastic Agents/therapeutic use , Female , Humans , Middle Aged , Young Adult
2.
Med Sante Trop ; 29(2): 206-212, 2019 May 01.
Article in English | MEDLINE | ID: mdl-31379350

ABSTRACT

Autoimmune diseases are a group of heterogeneous conditions responsible for polymorphic clinical and biological manifestations. Because pregnancy activates them and promotes gestational complications, it is difficult for women with these diseases. Pregnancy and autoimmune diseases have rarely been studied in sub-Saharan Africa. We report the experience of the Internal Medicine Department of the University Hospital of Libreville. Conducted retrospectively for 2008 through 2011, and prospectively from 2012 through August 31, 2018, this descriptive and analytical study examined the records at the Department of Internal Medicine of the University Hospital Center of Libreville of women with a known autoimmune disease, receiving regular care there, and who became pregnant after the diagnosis. During pregnancy, women were monitored and manÂged simultaneously in the departments of obstetrics and internal medicine. Data considered for this study were demographic data (Âge, sex, social status), type of autoimmune disease, including the diagnosis, the therapies used, extent of disease control, and time from diagnosis to each pregnancy. Obstetric data include the number of fetuses, obstetric complications, gestational Âge at and route of delivery, fetal sex, and Apgar score to 5 minutes (normal ≥ 7). Women had the following autoimmune diseases : systemic lupus erythematosus (SLE) (n = 16), Sjögren's disease (n = 3), inflammatory myopathy (n = 2), rheumatoid arthritis (n = 1), primary antiphospholipid syndrome (APS) (n = 1), and Still disease (n = 1).The overall averÂge Âge at diagnosis was 26.6 years (range : 13-40). The 24 women had 32 pregnancies. The mean interval from diagnosis to first pregnancy was 3.3 years, to the second pregnancy also 3.3 years (n = 6), and to the third (n = 2), 5 years. Disease was controlled for at least 2 years (n = 23) except for one woman with primary APS. Therapeutically, corticosteroids were used alone (n = 2) or combined with other immunomodulatory therapies (n = 32). Gestational complications included spontaneous abortions in the first trimester (n =2), in utero deaths (n = 2), perinatal death on day 12 (n = 1), and eclampsia (n = 2), one of which was complicated by a pulmonary embolism in the first pregnancy. The mean gestational Âge at delivery was 37 weeks. Intrauterine growth restriction affected 11 fetuses, and preterm delivery 18. There were 11 cesarean deliveries and 16 vaginal. Mean birth weight was 2353.3 grams, Apgar was ≥ 7 for all neonates except in one case of dermatomyositis complicating a neonatal death. The sex ratio was 13 male infants per 17 females. Women with optimal disease control can become pregnant and have positive pregnancy outcomes. This possibility has been little explored in sub-Saharan Africa; mystical-religious notions of conceptions persist and can prevent women from attempting to become prégnant . This experience with a short series of viable fetuses of women with autoimmune diseases is therefore encouraging and deserves to be continued.


Subject(s)
Autoimmune Diseases/epidemiology , Pregnancy Complications/epidemiology , Pregnancy Complications/immunology , Adolescent , Adult , Female , Gabon/epidemiology , Hospital Departments , Hospitals, University , Humans , Internal Medicine , Pregnancy , Retrospective Studies
3.
Bull Soc Pathol Exot ; 112(1): 12-13, 2019.
Article in French | MEDLINE | ID: mdl-31225731

ABSTRACT

Srongyloidiasis can sometimes be a source of diagnostic wandering in a patient with an autoimmune disease living in a tropical environment, despite systematic deworming with albendazole (400 mg/day/3 days), prior to the starting of a corticotherapy. We report an observation of a febrile gastroenteritis complicated by signs of intra and extracellular dehydration, in a 37-year-old lupus patient, including duodenal biopsies, and stool parasitology, which led to the diagnosis of strongyloidiasis effectively treated by ivermectin per os (two doses) of 200 micrograms/kg, once every 2 weeks apart), following failure of a first 5-days course of albendazole (400 mg/day).


L'anguillulose peut parfois être source d'errance diagnostique chez un patient porteur d'une maladie auto-immune vivant en milieu tropical, et ce malgré un déparasitage systématique par l'albendazole (40 mg/jour / 3 jours), avant la mise en route d'une corticothérapie. Nous rapportons une observation de gastroentérite fébrile, compliquée de signes de déshydratation intra et extracellulaire, chez une patiente lupique de 37 ans, dont les biopsies duodénales, et la parasitologie des selles ont conduit au diagnostic d'anguillulose traitée efficacement par ivermectine per os (2 doses de 200 microgrammes/kg, en prise unique à 2 semaines d'intervalle l'une de l'autre). Ce traitement faisait suite à l'échec d'un premier traitement par 5 jours d'albendazole (400 mg/jour).


Subject(s)
Gastroenteritis/parasitology , Lupus Erythematosus, Cutaneous/complications , Strongyloidiasis/complications , Adrenal Cortex Hormones/therapeutic use , Adult , Albendazole/therapeutic use , Antiparasitic Agents/therapeutic use , Biopsy , Duodenum/parasitology , Duodenum/pathology , Feces/parasitology , Female , Fever , Gabon , Gastroenteritis/drug therapy , Humans , Ivermectin/therapeutic use , Strongyloidiasis/diagnosis , Strongyloidiasis/drug therapy
4.
Med Sante Trop ; 29(2): 133-134, 2019 May 01.
Article in English | MEDLINE | ID: mdl-31145082

ABSTRACT

Loiasis is a chronic cutaneous disease caused by a filarial nematode for whom humans are the only definitive host: Loa loa, an African eyeworm transmitted by Chrysops flies. The parasite is seen on blood smears, in the skin, or during its ocular migration, but rarely on a bone marrow smear. We report the case of a 57-year-old Gabonese woman whose bone marrow aspiration during a work-up for T-cell leukemia fortuitously found Loa loa filariae.


Subject(s)
Bone Marrow/parasitology , Loa/isolation & purification , Loiasis/parasitology , Animals , Bone Marrow Examination , Female , Granulocyte Precursor Cells , Humans , Incidental Findings , Leukemia, Prolymphocytic, T-Cell/complications , Leukemia, Prolymphocytic, T-Cell/parasitology , Leukemia, Prolymphocytic, T-Cell/pathology , Loiasis/complications , Middle Aged
5.
Med. Afr. noire (En ligne) ; 64(12): 613-616, 2017.
Article in French | AIM (Africa) | ID: biblio-1266274

ABSTRACT

Les conditions bio-climatiques prédisposent à la transmission de la leptospirose au Gabon. Paradoxalement, cette affection est rarement voire peu diagnostiquée par les praticiens de ce pays. Nous rapportons une observation de leptospirose révélée par une fièvre au long cours


Subject(s)
Case Reports , Fever , Gabon , Jaundice , Leptospirosis
6.
Article in French | AIM (Africa) | ID: biblio-1265888

ABSTRACT

Le lupus familial est rare, et le mode de transmission complexe et polygénique. La transmission génétique serait liée à des gènes codant pour des traits auto-immuns, et à des gènes régulateurs ou accélérateurs de la maladie, dont l'expression serait amplifiée par l'environnement chez des patients/familles prédisposés. Les observations portant sur le caractère familial du lupus sont rarement retrouvées dans la revue de la littérature noire africaine. Nous rapportons les particularités retrouvées entre une mère et sa fille chez qui le diagnostic de lupus a été retenu sur les critères de l'American College of Rheumatology (ACR), dans une population de 103 patients lupiques régulièrement suivis dans le service de médecine interne du CHU de Libreville. Les manifestations cutanées, rhumatologiques, hématologiques et immunologiques étaient communes, la gravité moyenne du lupus lors du diagnostic dans les deux cas (SLEDAI à 9 et 11) mais sévère dans l'évolution de la maladie chez la fille ; avec des complications majeures (néphrite, vascularite, polyarthrite diffuse, diabète myopathie et ostéoporose cortico-induits, tuberculose). Le décès survenait à 2 ans du diagnostic chez la mère et 27 mois chez la fille


Subject(s)
Gabon , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/diagnosis , Lupus Erythematosus, Systemic/mortality , Patients
SELECTION OF CITATIONS
SEARCH DETAIL
...